- Home
- MNPR vs MGPI Comparison
MNPR vs MGPI Comparison
Compare MNPR & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | MGPI |
|---|---|---|
| Founded | 2014 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 533.0M |
| IPO Year | 2019 | 1988 |
Fundamental Metrics
Financial Performance| Metric | MNPR | MGPI |
|---|---|---|
| Price | $76.19 | $25.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $97.83 | $40.00 |
| AVG Volume (30 Days) | 163.8K | ★ 400.4K |
| Earning Date | 11-13-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $578,855,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.00 | $21.67 |
| 52 Week High | $105.00 | $46.90 |
Technical Indicators
Market Signals| Indicator | MNPR | MGPI |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 59.26 |
| Support Level | $74.51 | $23.75 |
| Resistance Level | $79.31 | $26.62 |
| Average True Range (ATR) | 6.38 | 0.99 |
| MACD | -0.93 | 0.37 |
| Stochastic Oscillator | 6.10 | 86.67 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.